Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Adaptimmune Therapeutics (ADAP) will resume trading at 4:35pm ET
November 9, 2016 4:13 PM ESTAdaptimmune Therapeutics (NASDAQ: ADAP) will resume trading at 4:35pm EST.
... MoreAdaptimmune Therapeutics (ADAP) Announces Lift of FDA Partial Clinical Hold on NY‑ESO SPEAR in MRCLS
November 9, 2016 4:06 PM ESTAdaptimmune Therapeutics plc (Nasdaq: ADAP) announced that the U.S. Food and Drug Administration has removed the partial clinical hold on the planned study of its NYESO SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell therapy in MRCLS.
Under a revised protocol,... More
Adaptimmune Therapeutics (ADAP), Novavax (NVAX) trading halted with news pending.
November 9, 2016 4:01 PM ESTAdaptimmune Therapeutics (NASDAQ: ADAP), Novavax (NASDAQ: NVAX) trading halted with news pending.
... More